SANDOZ EDOXABAN 60 MG — DIN 02553430
EDOXABAN (EDOXABAN TOSYLATE MONOHYDRATE) : 60 MG · SANDOZ CANADA INCORPORATED · TABLET · wholesale supply in Canada
Health Canada status: MARKETED
What is SANDOZ EDOXABAN?
SANDOZ EDOXABAN 60 MG contains EDOXABAN (EDOXABAN TOSYLATE MONOHYDRATE) : 60 MG. It is listed in the Health Canada Drug Product Database under DIN 02553430, held by SANDOZ CANADA INCORPORATED, supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 06-May-2025. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is SANDOZ EDOXABAN used for?
Sandoz Edoxaban (edoxaban tablets) is indicated for: • Prevention of stroke and systemic embolic events in patients with atrial fibrillation, in whom anticoagulation is appropriate. • Treatment of venous thromboembolism (VTE) (deep vein thrombosis [DVT], pulmonary embolism [PE]) and the prevention of recurrent DVT and PE.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
How much does Edoxaban cost around the world?
Edoxaban is listed on 7 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Austria publishes a KVP (Kassenverkaufspreis); Czechia publishes a max producer price (ex-factory); Hungary publishes a producer price (ex-factory). Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed | Range |
|---|---|---|---|---|
| Czechia | max producer price (ex-factory) | 7 | 22 | CZK███.██ |
| Hungary | producer price (ex-factory) | 16 | 19 | HUF███.██ |
| Iceland | max wholesale | 3 | 11 | ISK███.██ |
| Romania | max producer price | 9 | 11 | RON███.██ |
| Austria | KVP (Kassenverkaufspreis) | 3 | 5 | EUR███.██ |
| Luxembourg | reimbursement | 5 | 5 | EUR███.██ |
| Italy | prezzo al pubblico (classe A) | 3 | 3 | EUR███.██ |
76 pack listings across 46 brand entries and 7 price bases, refreshed 05 Sep 2026. Ranges span every Edoxaban pack in that market, so a high figure is usually a larger pack rather than the same product.
Canada publishes no comparable public list price. For a delivered Canadian price on a licensed account, verify your licence — it takes about a minute.
Is there a generic Edoxaban in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
6 holders have a Canadian DIN containing Edoxaban, across 18 DINs, of which 10 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| SANDOZ CANADA INCORPORATED | 3 | 3 | SANDOZ EDOXABAN | Sourceable in Canada |
| TEVA CANADA LIMITED | 3 | 3 | TEVA-EDOXABAN | Sourceable in Canada |
| JAMP PHARMA CORPORATION | 3 | 2 | JAMP EDOXABAN | Sourceable in Canada |
| PRO DOC LIMITEE | 3 | 2 | PRO-EDOXABAN | Sourceable in Canada |
| DR REDDY'S LABORATORIES LTD | 3 | 0 | REDDY-EDOXABAN | No marketed DIN |
| SERVIER CANADA INC | 3 | 0 | LIXIANA | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 60 MG |
|---|---|
| Dosage form | TABLET |
| Route | ORAL |
| Pack configuration (monograph) | Sandoz Edoxaban tablets are supplied in HDPE bottles containing: • 30 tablets or 100 tablets for 15 mg strength. • 30 tablets, 100 tablets or 500 tablets for 30 mg strength. • 30 tablets, 100 tablets or 500 tablets for 60 mg strength. |
| Storage | null |
Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Substance and classification
| Active substance | Edoxaban |
|---|---|
| ATC code | B01AF03 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02553430 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2553430 |
| Brand name | SANDOZ EDOXABAN |
| Generic / active ingredient | EDOXABAN (EDOXABAN TOSYLATE MONOHYDRATE) : 60 MG |
| Market authorization holder | SANDOZ CANADA INCORPORATED |
| Health Canada schedule | Prescription |
| ATC code | B01AF03 |
| ATC anatomical main group | B — Blood and blood-forming organs |
| ATC therapeutic subgroup | B01AF |
| Current status | MARKETED |
| Status date | 06-May-2025 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
10 of 18 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| JAMP EDOXABAN | 60 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED | 02557290 |
| JAMP EDOXABAN | 30 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED | 02557282 |
| PRO-EDOXABAN | 60 MG | TABLET | PRO DOC LIMITEE | MARKETED | 02556979 |
| PRO-EDOXABAN | 30 MG | TABLET | PRO DOC LIMITEE | MARKETED | 02556960 |
| SANDOZ EDOXABAN | 30 MG | TABLET | SANDOZ CANADA INCORPORATED | MARKETED | 02553422 |
| SANDOZ EDOXABAN | 15 MG | TABLET | SANDOZ CANADA INCORPORATED | MARKETED | 02553414 |
| TEVA-EDOXABAN | 15 MG | TABLET | TEVA CANADA LIMITED | MARKETED | 02554208 |
| TEVA-EDOXABAN | 30 MG | TABLET | TEVA CANADA LIMITED | MARKETED | 02554216 |
| TEVA-EDOXABAN | 60 MG | TABLET | TEVA CANADA LIMITED | MARKETED | 02554224 |
| JAMP EDOXABAN | 15 MG | TABLET | JAMP PHARMA CORPORATION | APPROVED | 02557274 |
2 · Same class — other molecules in ATC B01AF
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Rivaroxaban | ACH-RIVAROXABAN · AG-RIVAROXABAN · APO-RIVAROXABAN · AURO-RIVAROXABAN · +17 more | 97 | 68 | Yes |
| Apixaban | ACH-APIXABAN · AG-APIXABAN · APIXABAN · APO-APIXABAN · +17 more | 44 | 43 | Yes |
| Edoxaban | JAMP EDOXABAN · LIXIANA · PRO-EDOXABAN · REDDY-EDOXABAN · +2 more | 18 | 10 | Yes |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC B01A
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| B01AB | Antithrombin · Dalteparin · Danaparoid · Enoxaparin · Heparin · +3 more | 128 | 82 |
| B01AC | Abciximab · Acetylsalicylic Acid · Cangrelor · Clopidogrel · Combinations · +10 more | 158 | 66 |
| B01AA | Acenocoumarol · Warfarin | 62 | 16 |
| B01AE | Argatroban · Bivalirudin · Dabigatran Etexilate · Lepirudin | 18 | 11 |
| B01AX | Caplacizumab · Defibrotide · Fondaparinux | 10 | 5 |
| B01AD | Alteplase · Ancrod · Anistreplase · Drotrecogin Alfa · Reteplase · +3 more | 22 | 4 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is SANDOZ EDOXABAN called?
The same molecule, Edoxaban, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Lixiana | Latin | Czechia, Iceland |
| EDOXABAN STADA | Latin | Czechia |
| Edoxaban Krka | Latin | Iceland |
| EDOXABAN SANDOZ | Latin | Czechia |
| EDOXABAN VIATRIS | Latin | Czechia |
| DELIANDA | Latin | Czechia |
| EDOXABAN +PHARMA | Latin | Czechia |
| Edoxaban WH | Latin | Iceland |
| SETIAPO | Latin | Czechia |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.